FDMT Stock Summary and Trading Ideas (4D Molecular Therapeutics | NASDAQ:FDMT)

4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).

What symbol and exchange does 4D Molecular Therapeutics shares trade?

4D Molecular Therapeutics trades on the NASDAQ stock market under the symbol FDMT.

What is 4D Molecular Therapeutics stock price doing today?

As of May 1, 2026, FDMT stock price climbed to $9.09 with 768,796 million shares trading.

What is 4D Molecular Therapeutics's Beta?

FDMT has a beta of 0.88, meaning it tends to be less sensitive to market movements. FDMT has a correlation of 0.03 to the broad based SPY ETF.

How much is 4D Molecular Therapeutics worth?

FDMT has a market cap of $475.18 million. This is considered a Small Cap stock.

How much money does 4D Molecular Therapeutics make?

Last quarter 4D Molecular Therapeutics reported $85 million in Revenue and $.43 earnings per share. This beat revenue expectation by $53 million and exceeded earnings estimates by $.96.

What is the highest and lowest price 4D Molecular Therapeutics traded in the last 3 year period?

In the last 3 years, FDMT traded as high as $36.25 and as low as $2.24.

What are the top ETFs holding 4D Molecular Therapeutics?

The top ETF exchange traded funds that FDMT belongs to (by Net Assets): VTI, XBI, IWM, VXF, IWN.

Is 4D Molecular Therapeutics (FDMT) a good investment?

FDMT has outperformed the market in the last year with a return of +164.2%, while the SPY ETF gained +30.4%. However, in the most recent history, FDMT shares have underperformed the stock market with its stock returning +2.6% in the last 3 month period and -13.3% for the last 2 week period, while SPY has returned +4.4% and +1.5%, respectively.

What are the support and resistance levels for 4D Molecular Therapeutics (FDMT)?

FDMT support price is $8.55 and resistance is $9.19 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that FDMT shares will trade within this expected range on the day.